Gem Aromatics Limited · NSE:GEMAROMA
Gem Aromatics — Q1 FY2027 Earnings Presentation
32 slides from Gem Aromatics's earnings presentation, August 2026
Slide 1: Investor Presentation Q1FY27
Investor Presentation Q1FY27
Slide 2: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), has been prepared by Gem Aromatics Ltd (the “Company”), solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the bas
Slide 3: Table of Contents
Table of Contents Q1FY27 Highlights Company Overview Annual Financials Annexure 3
Slide 4: Q1FY27 Highlights
AROMATICS Q1FY27 Highlights Ci GEM
Slide 5: Management Commentary
Management Commentary Q1FY27 witnessed YoY growth in revenue from operations, while the business continued to operate in a seasonally softer quarter. As we look ahead, our focus is increasingly shifting towards utilizing and monetising the expanded manufacturing platform at Dahej and scaling the new
Slide 6: Q1FY27 Financial Performance
Q1FY27 Financial Performance Revenue Gross Margin & PAT Cash PAT (Rs Cr) EBITDA Margin (%) (Rs Cr) (Rs Cr) 17.7 % Standalone (Gross Margin declined from Rs 83.0 Cr 25.0 % in Q1FY26) Rs 7.3 Cr Rs 8.9 Cr 9% YoY 10.3 % 11% YoY 11% YoY (EBITDA Margin declined from 13.8 % in Q1FY26) 16.7% Consolida
Slide 7: Key Business Updates
Key Business Updates Revenue & Market Environment Q1FY27 revenue from operations recorded YoY growth, reflecting an improvement in underlying business activity. The quarter is seasonally softer, while the Clove business was impacted by floods in Madagascar, resulting in higher raw material prices an
Slide 8: Standalone Profit & Loss Statement
Standalone Profit & Loss Statement Particulars (Rs Cr) Q1FY27 Q1FY26 YoY (%) Q4FY26 QoQ (%) Net Revenue From Operations 83.0 76.4 8.6% 112.2 -26.1% Cost of Goods Sold 68.3 57.3 86.0 Gross Profit 14.7 19.1 -23.2% 26.2 -44.0% Gross Profit Margin (%) 17.7% 25.0% -734 bps 23.4% -566 bps Employee Expense
Slide 9: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement Particulars (Rs Cr) Q1FY27 Q1FY26 YoY (%) Q4FY26 QoQ (%) Net Revenue From Operations 98.9 87.6 12.8% 110.4 -10.5% Cost of Goods Sold 82.3 61.8 76.7 Gross Profit 16.5 25.9 -36.2% 33.7 -51.0% Gross Profit Margin (%) 16.7% 29.5% -1282 bps 30.5% -1384 bps Employee Ex
Slide 10: Company Overview
AROMATICS Company Overview 6 GEM
Slide 11: A Journey of 3 Decades leading to Growth and Transformation
~A Journey of 3 Decades leading to Growth and Transformation… 1997 2008 2009 2013 2016 2018 Incorporated our Executed the first Introduced a new Received Star Export Commenced production Achieved Rs 1,648 Mn in Company and export order vertical – Clove oil House status at Unit II – Budaun, U.P reven
Slide 12: Established Scale with a Strong Market Presence
…Established Scale with a Strong Market Presence • One of the leading Indian manufacturer of specialty ingredients, including essential oils, aroma chemicals, and value-added derivatives. • Company offers a wide range of products across Mint, Clove, Phenol, and other natural and synthetic ingredient
Slide 13: Mint & Mint Derivative – Well Established Business
Mint & Mint Derivative – Well Established Business • Largest business segment with strong customer demand • Widely used in Oral Care, Pharma, Nutraceuticals, Personal Care, Wellness • With a facility in the Budaun mint belt (UP), we benefit from easy, cost-efficient access to quality mint raw materi
Slide 14: Clove & Clove Derivatives – High-Value Segment with Leadership in Eugenol
Clove & Clove Derivatives – High-Value Segment with Leadership in Eugenol • Second-largest Revenue contributor with Strong Margin Profile • One of the largest processors of Clove Oil and Eugenol (by volume in India, FY25) • Used in Flavor, Dental Care, Pharma, Fragrance Applications Products Growth
Slide 15: Entering Advanced Chemistry with Phenol Derivatives
Entering Advanced Chemistry with Phenol Derivatives • Diversified phenolic portfolio serving pharma, antioxidant and fragrance applications. • Sustainable vapor-phase technology ensures high-purity output with near-zero effluent. • Forward-integrated processes enable entry into limited-competition,
Slide 16: Citral Chemistry and Other Natural & Synthetic Ingredients
Citral Chemistry (New Products) and Other Natural & Synthetic Ingredients Natural & Synthetic • Largest processor of Eucalyptus Oil in India with ~58% Citral Chemistry market share (FY25)* New Products Ingredients • Diversified sourcing of crude eucalyptus & botanicals Entering into High-Value Aroma
Slide 17: Focus on Growing Value-Added Products
Focus on Growing Value-Added Products – From Base to Advanced Molecules Category Mother Ingredient/ Base Product Advanced / Specialty Products Industry Peppermint Mint & Mint GEM Cool 05 • Oral Care Spearmint Derivatives GEM Cool 03 Menthol • Cosmetics Clove & Clove Eugenol • Nutraceuticals Clove Le
Slide 18: Experienced Promoters and Management Team (1/2)
Experienced Promoters and Management Team…(1/2) Promoters and Directors Vipul Parekh Kaksha Vipul Parekh Yash Vipul Parekh Whole-Time Director Whole-Time Director, Chairperson and CFO Managing Director and Chief Executive Officer • Associated with the company since inception • Associated with the co
Slide 19: Experienced Promoters and Management Team (2/2)
Experienced Promoters and Management Team…(2/2) Dinesh T V Shrenik Vora CA Nandan Narula Dr. Ajay Sahai Vishakha Bhagvat Dr. Parag Gogate Dr. Shubhangi Umbarkar Additional WTD Non-Executive Director Independent Directors Independent Directors Independent Directors Independent Directors Independent D
Slide 20: Strategically Located Manufacturing Facilities with Advanced Capabilities
Strategically Located Manufacturing Facilities with Advanced Capabilities Dahej Access to Phenol and Excellent Connectivity via Budaun Expressway and Located in India’s Ports. prime Mint Cultivation Belt. Silvassa Facility Budaun Facility Dahej Facility (1997) (2016) (2024) Products Manufactured: Pr
Slide 21: Fueling Future Growth – Greenfield Project at Dahej
Fueling Future Growth – Greenfield Project at Dahej Key Plant Highlights Key Business Update ✓ Cooling Agents: Customer audits completed and initial orders secured for GEM Cool 03, GEM Cool 05 and GEM Cool 23. Revenue contribution expected from Q3FY27. ✓ Safranal: Revenue contribution expected towar
Slide 22: From India to the World: Strengthening Our Global Presence
From India to the World: Strengthening Our Global Presence Serving 240 domestic and Germany 44 international customers Bulgaria United across 20 countries Kingdom USA Ireland Netherlands France Turkey China Strategic investor Israel Hong Kong and customer Spain India Vietnam Thailand Nepal Indonesia
Slide 23: Complex Chemistries Process Technology
With Complex and Advanced End-to-End Processes Journey of a Molecule Raw Material Arrival Extraction & Isolation Complex Chemistry In-Action Automated Quality & Analytics Final Formulation & Packaging Quality checked, tracked, and Botanicals and petrochemicals Breakthrough molecules and derivatives
Slide 24: Strong and Robust R&D Capabilities Driving Innovation
Strong and Robust R&D Capabilities Driving Innovation Structured R&D Focus Areas Existing Product Innovation: Portfolio Expansion: Strategic Market Targeting: ✓ Improving yields, selectivity, and process ✓ New molecules, new chemistry, and step ✓ Identifying high-demand products with limited efficie
Slide 25: Annual Financials
Annual Financials AROMATICS
Slide 26: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement Particulars (Rs Cr) FY23 FY24 FY25 FY26 Net Revenue From Operations 424.8 452.5 504.0 366.5 Cost of Goods Sold 317.4 341.2 378.7 276.1 Gross Profit 107.4 111.3 125.2 90.3 Gross Profit Margin (%) 25.3% 24.6% 24.8% 24.6% Employee Expenses 10.8 11.1 12.8 16.4 Other
Slide 27: Consolidated Balance Sheet
Consolidated Balance Sheet Liabilities (Rs Cr) Mar-23 Mar-24 Mar-25 Mar-26 Assets (Rs Cr) Mar-23 Mar-24 Mar-25 Mar-26 Property, Plant & Equipment Share Capital 1.8 9.4 9.4 10.4 26.4 40.3 43.4 243.1 and Intangible Assets Reserves & Surplus 177.7 221.2 274.6 439.5 Capital Works-in-progress 10.9 30.4 1
Slide 28: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Particulars (Rs Cr) FY23 FY24 FY25 FY26 Net Profit Before Tax and Extraordinary Items 56.1 67.6 74.4 6.4 Adjustments for: Non-Cash Items / Other Investment or 15.8 10.4 15.4 40.1 Financial Items Operating Profit Before Working Capital Changes 71.9 78.0 89.8 46.4 Chan
Slide 29: Annexure
Annexure AROMATICS
Slide 30: Dahej Plant Pictures
|| Dahej Plant Pictures 30
Slide 31: Stock Information & Shareholding Pattern
Stock Information & Shareholding Pattern Capital Market Information (as on 13th August 2026) Shareholding Pattern (as on 30th June 2026) BSE/NSE Code 544491/ GEMAROMA Public Promoters 37.0% 57.4% CMP (Rs) 174.90 Market Cap (Rs Cr) 914.15 Shares (Cr) 5.2 DII's 4.8% FII's Face Value (Rs) 2.00 0.8% 31
Slide 32: Thank You
Thank You Gem Aromatics Ltd Stellar IR Advisors Pvt. Ltd. CIN No. L24246MH1997PLC111057 Akshita Gohil Akhilesh Gandhi, CFA | akhilesh@stellar-ir.com secretarial@gemaromatics.in Omkar Sawant| omkar@stellar-ir.com Phone: 9322121990 | 022 25185231 Phone: 022 62398024 www.gemaromatics.com www.stellar-ir